We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

High Glaucoma Risk in Pseudoexfoliation Syndrome: Age and Ocular Hypertension Drive Incidence

MedXY Editorial Team•Apr 23, 2026•news
Cataract surgeryglaucoma riskocular hypertensionpseudoexfoliation syndrome

Clinical Context: Pseudoexfoliation as a Glaucoma Time Bomb

Pseudoexfoliation syndrome (PXF), characterized by abnormal extracellular material deposition in ocular tissues, affects 10-20% of adults over 60 worldwide. This study addresses critical gaps in understanding its progression to perimetric glaucoma – the stage where visual field defects become detectable. While 30-50% of PXF patients develop ocular hypertension (OHTN), the risk in normotensive PXF eyes remains poorly quantified.

Study Design: NLP-Powered Retrospective Analysis

Researchers analyzed 485 eyes from 369 patients (2016-2023) at a tertiary center using:

  • Natural language processing to identify PXF cases from electronic records
  • PyGlaucoMetrics algorithm for objective glaucoma detection from Humphrey Visual Fields
  • Kaplan-Meier analysis for cumulative incidence and Cox regression for risk factors

Key Findings: Glaucoma Incidence and Risk Stratification

The 4-year glaucoma incidence diverged sharply:

  • 26.5% (20.7-32.0%) in PXF without OHTN
  • 37.5% (24.3-48.4%) in PXF with OHTN (P=0.005)

Multivariable analysis revealed independent risk factors:

Factor Hazard Ratio 95% CI
Age (per 5 years) 1.39 1.19-1.62
Ocular Hypertension 2.18 1.39-3.42
Cup-to-Disc Ratio (per 0.1) 1.17 1.04-1.31
Phakia (vs Pseudophakia) 1.94 1.13-3.34

The OHTN Paradox in Glaucoma Development

Despite OHTN being a major risk factor, 87.3% of eyes that progressed to glaucoma had no documented OHTN at any visit. This suggests:

  • IOP spikes may occur outside office hours
  • Non-IOP dependent mechanisms (e.g., direct optic nerve toxicity from PXF material)

Intervention Outcomes: Lens Extraction Shows Promise

Standalone cataract surgery in PXF eyes reduced:

  • Mean IOP from 15.8 ± 2.5 mmHg to 12.9 ± 2.7 mmHg at 1 year
  • Glaucoma medication use from 0.40 ± 0.78 to 0.28 ± 0.57

Clinical Implications and Limitations

The findings demand:

  • More frequent monitoring of PXF patients regardless of IOP
  • Consideration of early lens extraction in phakic patients

Study limitations include its retrospective design and potential undercapture of IOP fluctuations.

Conclusion

This study quantifies the substantial glaucoma risk in PXF, revealing that nearly 90% of conversions occur without documented OHTN. The protective effect of lens extraction warrants further investigation as a potential disease-modifying intervention.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Understanding Contemporary Intraocular Lens-Associated Uveitis-Glaucoma-Hyphema (UGH) Syndrome: Clinical Insights and ManagementThis article reviews clinical characteristics, onset timing, management, and outcomes of intraocular lens-associated UGH syndrome, highlighting challenges with late-onset disease and persistent ocular hypertension despite treatment.Aug 23, 2026Increased Risk of Pseudophakic Cystoid Macular Edema After Cataract Surgery in Eyes with Prior Pars Plana Vitrectomy: Insights from a Large Retrospective Cohort StudyThis study reveals that eyes with previous pars plana vitrectomy exhibit a significantly higher risk of cystoid macular edema following cataract surgery, underscoring the need for careful postoperative monitoring and potential prophylaxis sAug 4, 2026Fungal Endophthalmitis Associated with Contaminated Trypan Blue in Cataract Surgery: A Retrospective Case SeriesSix cases of postoperative fungal endophthalmitis caused by Sarocladium kiliense following cataract surgery involving contaminated trypan blue are reported, highlighting diagnosis, management, and outcomes.Jul 24, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Nicotinamide Supplementation and Primary Open-Angle Glaucoma in Patients With Ocular Hypertension: Evidence, Mechanisms, and Clinical ImplicationsSystemic nicotinamide supplementation is associated with reduced risk of POAG development in ocular hypertension, improved retinal function, and better quality of life, suggesting its neuroprotective potential as an adjunctive therapy in glJul 11, 2026
Assessing the Impact of Cataract Surgery on Progression from Dry to Neovascular Age-Related Macular Degeneration: Insights from the IRIS® RegistryA large retrospective study from the IRIS® Registry reveals a modest, time-dependent increase in neovascular AMD risk following cataract surgery in patients with dry AMD, with implications for perioperative evaluation and patient counselingJun 25, 2026
Clobetasol Propionate Ophthalmic Suspension 0.05%: A New Therapeutic Milestone in Post-Cataract Surgery Inflammation and Pain ManagementThis review synthesizes clinical evidence for CPN 0.05% (BYQLOVI®), highlighting its rapid efficacy, superior pain resolution, and favorable safety profile compared to traditional ocular steroids following cataract surgery.May 12, 2026